Abstract
The inability to engage in the usual activities of daily living is one of the most distressing experiences of people afflicted with chronic obstructive pulmonary disease (COPD). Exercise intolerance progresses relentlessly as the disease advances, contributing to reduced quality of life. It has become clear that in COPD, exercise intolerance ultimately reflects complex integrated abnormalities of the ventilatory, cardiovascular, peripheral muscle and neurosensory systems that vary in degree from patient to patient. Ventilatory limitation and perceived respiratory difficulty are often the dominant contributors to exercise curtailment in more advanced disease, but not necessarily the only ones. Recently, there has been great interest in the role of cardiovascular and peripheral muscle dysfunction (and their interaction) in exercise limitation in COPD. In this review, we examine in some detail the pathophysiological derangements that are evident during exercise in COPD with the hope of identifying specific mechanisms that are amenable to therapeutic manipulation.
Keywords: COPD, exercise, ventilatory mechanics, dyspnea, dynamic hyperinflation, muscle dysfunction, energy metabolism
Current Respiratory Medicine Reviews
Title: Exercise Limitation in Chronic Obstructive Pulmonary Disease
Volume: 4 Issue: 4
Author(s): Pierantonio Laveneziana, Karin Wadell, Katherine Webb and Denis E. O'Donnell
Affiliation:
Keywords: COPD, exercise, ventilatory mechanics, dyspnea, dynamic hyperinflation, muscle dysfunction, energy metabolism
Abstract: The inability to engage in the usual activities of daily living is one of the most distressing experiences of people afflicted with chronic obstructive pulmonary disease (COPD). Exercise intolerance progresses relentlessly as the disease advances, contributing to reduced quality of life. It has become clear that in COPD, exercise intolerance ultimately reflects complex integrated abnormalities of the ventilatory, cardiovascular, peripheral muscle and neurosensory systems that vary in degree from patient to patient. Ventilatory limitation and perceived respiratory difficulty are often the dominant contributors to exercise curtailment in more advanced disease, but not necessarily the only ones. Recently, there has been great interest in the role of cardiovascular and peripheral muscle dysfunction (and their interaction) in exercise limitation in COPD. In this review, we examine in some detail the pathophysiological derangements that are evident during exercise in COPD with the hope of identifying specific mechanisms that are amenable to therapeutic manipulation.
Export Options
About this article
Cite this article as:
Laveneziana Pierantonio, Wadell Karin, Webb Katherine and O'Donnell E. Denis, Exercise Limitation in Chronic Obstructive Pulmonary Disease, Current Respiratory Medicine Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157339808786263752
DOI https://dx.doi.org/10.2174/157339808786263752 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential
Current Medicinal Chemistry Leptin and Vascular Smooth Muscle
Current Vascular Pharmacology Beta-Adrenergic Antagonists: Indications and Potential Immunomodulatory Side Effects in the Critically Ill
Current Medicinal Chemistry Cerebral Artery Signal Transduction Mechanisms: Developmental Changes in Dynamics and Ca<sup>2+</sup> Sensitivity
Current Vascular Pharmacology Traumatic Brain Injury as a Risk Factor for Alzheimer’s Disease: Is Inflammatory Signaling a Key Player?
Current Alzheimer Research Non-Infectious Complications of Immunosuppressant Medications in Renal Transplant Patients
Current Clinical Pharmacology Anabolic Androgenic Steroids and Intracellular Calcium Signaling: A Mini Review on Mechanisms and Physiological Implications
Mini-Reviews in Medicinal Chemistry Stem Cell-Derived Motor Neurons: Applications and Challenges in Amyotrophic Lateral Sclerosis
Current Stem Cell Research & Therapy Bone Marrow Stem Cell Therapy for Myocardial Angiogenesis
Current Vascular Pharmacology Pompe Disease and Autophagy: Partners in Crime, or Cause and Consequence?
Current Medicinal Chemistry Neuregulin1 as Novel Therapy for Heart Failure
Current Pharmaceutical Design Hypoxia-Inducible Factor-1 (HIF-1): A Potential Target for Intervention in Ocular Neovascular Diseases
Current Drug Targets Cardiovascular Pharmacogenetics of Antihypertensive and Lipid- Lowering Therapies
Current Molecular Medicine Recent Patents Concerning Modulators of Protein Kinase C
Recent Patents on DNA & Gene Sequences High-output Cardiac Failure: A Forgotten Phenotype in Clinical Practice
Current Cardiology Reviews Autoimmune Fibrotic Adverse Reactions in One-Year Treatment with Cabergoline for Women with Prolactinoma
Endocrine, Metabolic & Immune Disorders - Drug Targets Myocardial Expression of TNF-α, IL-1β, IL-6, IL-8, IL-10 and MCP-1 After a Single MDMA Dose Administered in a Rat Model
Current Pharmaceutical Biotechnology Future Targets in Endothelial Biology: Endothelial Cell to Mesenchymal Transition
Current Drug Targets The Road to Device Miniaturization in Echocardiography
Recent Patents on Medical Imaging Microenvironmental Determinants of Adult Neural Stem Cell Proliferation and Lineage Commitment in the Healthy and Injured Central Nervous System
Current Stem Cell Research & Therapy